Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
DAK HEALTH has floated a tender for Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for the Active Ingredient Perindopril and Amlodipine, Atc C09bb04 for the Period April 1, 2023 - March 31, 2025. The project location is Germany and the tender is closing on 05 Feb 2025. The tender notice number is 105950-2023, while the TOT Ref Number is 79106645. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Germany
Summary : Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for the Active Ingredient Perindopril and Amlodipine, Atc C09bb04 for the Period April 1, 2023 - March 31, 2025
Deadline : 05 Feb 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 79106645
Document Ref. No. : 105950-2023
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : EUR 1.00
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
§ 130a paragraph 8 SGB V enables the health insurance companies and pharmaceutical companies to conclude framework discount agreements for the drugs to be supplied at the expense of the statutory health insurance companies. With regard to the relevant statutory provisions on the award of public contracts, findet a regular process of active substance-related, formal award procedures according to the regulations of the 4th part of the GWB by the DAK-Gesundheit. For pharmaceuticals to be specified by the bidder in Annex 2 to the contract for the above-mentioned Active substance perindopril and amlodipine, ATC C09BB04, intendedDAK-Gesundheit to conclude drug discount contracts with as many interested pharmaceutical companies as possible before new drug discount contracts come into force. A discount agreement in the context of the admission model for the above The active substance comes into force for the first time on April 1st, 2023 and ends on April 3rd, 202303/01/2025. Irrespective of this, it ends automatically when the exclusive contract comes into force.
Doc Title: Pharmaceutical products
Contract Type: Supplies
Document Type : Contract notice
Reference Number : 1003860 - Perindopril und Amlodipin, ATC C09BB04
Contract Type : Supplies
Estimated Value : 1.00 - EUR
33600000 - Pharmaceutical products
Authority Type : Body governed by public law
Type of Procedure : Open procedure
Regulation : European Union
Bid Type : Submission for all lots
Doc Title : Pharmaceutical products
Dispatch Date : 2023-02-15
Publish Date : 2023-02-20
Submission Date : 2025-02-05
Documents
Want To Bid in This Tender?
Get Local Agent Support in Germany and 60 More Countries.
View Tenders By
Sign in with Google